LKC Technologies
Português
Português English Español 日本
  • Produtos
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Tiras de sensor
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Aplicações
    • Testes e ERG
      • Electroretinography (ERG)
      • Potencial Evocado Visual (PEV)
    • Condições Clínicas
      • Retinopatia Diabética
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Aplicações em animais
  • Recursos
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Pesquisa
    • Blog
    • Videos
    • Software
  • Sobre a LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • Depoimentos
    • História
  • Contato
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips

Retinopatia Diabética

Show:

RETeval
Tiras de sensor
RETevet
Menu
  • Animal
  • Central Retinal Vein Occlusion
  • Retinopatia Diabética
  • Flicker ERG
  • Inherited Retinal Diseases
  • Optic Nerve Disorders
  • Pediatric
  • Photopic Negative Response
  • Tiras de sensor

Electroretinograms Recorded with Skin Electrodes from Post-Vitrectomy Silicone Oil Filled Eyes with Proliferative Diabetic Retinopathy

Julho 30, 2024
Kanai K, Igawa Y, Tachibana M, et al. Electroretinograms Recorded with Skin Electrodes from Post-Vitrectomy Silicone Oil Filled Eyes with Proliferative Diabetic Retinopathy. Published online July 30, 2024.

Visual Function Measurements in Eyes with Diabetic Retinopathy: An Expert Opinion on Available Measures

Abril 6, 2024
Glassman AR, Elmasry MA, Baskin DE, et all. Ophthalmology Science. 2024.

Electrophysiological findings in long-term type 1 diabetes patients without diabetic retinopathy using different ERG recording systems

Fevereiro 12, 2024
Arias-Alvarez M, Tomas-Grasa C, Sopeña-Pinilla M, et al. Sci Rep. 2024;14(1):3520.

Early diabetic eye damage: Comparing detection methods using diagnostic power

Janeiro 30, 2024
Rai BB, Kleef JP van, Sabeti F, Vlieger R, Suominen H, Maddess T. Early diabetic eye damage: Comparing detection methods using diagnostic power. Published online January 2024.

Improved predictive diagnosis of diabetic macular edema based on hybrid models: An observational study

Janeiro 11, 2024
Hughes-Cano JA, Quiroz-Mercado H, Hernández-Zimbrón LF, et al. Computers in Biology and Medicine. 2024;170:107979. doi:10.1016/j.compbiomed.2024.107979

What else can we do to prevent diabetic retinopathy?

Junho 6, 2023
Simó R, Hernández C. What else can we do to prevent diabetic retinopathy. Published online June 6, 2023.

The association between decreased choriocapillary flow and electroretinogram impairments in patients with diabetes

Junho 1, 2023
Deng X. Photodiagnosis and Photodynamic Therapy. Volume 42, June 2023.
Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes

Multimodal testing reveals subclinical neurovascular dysfunction in prediabetes, challenging the diagnostic threshold of diabetes.

Março 31, 2023
Kirthi V, Reed KI, Alattar K, et al. Diabet Med. 2023;40(3):e14952.

Preventable risk factors for type 2 diabetes can be detected using noninvasive spontaneous electroretinogram signals

Janeiro 12, 2023
Noguez Imm R, Muñoz-Benitez J, Medina D, et al. Barnes S, ed. PLoS ONE. 2023;18(1):e0278388. doi:10.1371/journal.pone.0278388

Are we overlooking the neurodegeneration in the early stage of Type 1 Diabetes Mellitus without Visual Impairment or Diabetic Retinopathy?

Novembro 29, 2022
Jia Y, Lin Q, Xiao Y, Zhou X, Zou H, Yang C. Current Eye Research. Published online November 24, 2022:1-17.

Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy

Agosto 23, 2021
Simó R, Simó-Servat O, Bogdanov P, Hernández C. Neurovascular Unit: A New Target for Treating Early Stages of Diabetic Retinopathy. Published online August 23, 2021.

A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models

Outubro 14, 2020
Pearce E, Sivaprasad S. A Review of Advancements and Evidence Gaps in Diabetic Retinopathy Screening Models. Clinical Ophthalmology. Published online October 14, 2020.

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

Agosto 4, 2020
Mitchell G. Brigell; Bryce Chiang; April Yauguang Maa; C. Quentin Davis. Translational Vision Science & Technology August 2020, Vol.9, 40.
2006_predictive-value-of-erg-oct-a-and-uwf-fa-in-patients-with-diabetic-retinopathy_abstract

Predictive Value of ERG, OCT-A, and UWF-FA in Patients with Diabetic Retinopathy

Junho 1, 2020
This abstract assesses the value of electroretinography (ERG), OCT-angiography (OCT-A), and ultra-wide field fluorescein angiography (UWF-FA) parameters to predict progression…
Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device

Screening for diabetic retinopathy in diabetic patients with a mydriasis-free, full-field flicker electroretinogram recording device

Novembro 1, 2019
According to this study published in China, the DR assessment protocol in RETeval device was effective in screening for Diabetic…
Retinal Vasculature-function

Retinal vasculature–function correlation in non-proliferative diabetic retinopathy

Outubro 1, 2019
The purpose of this publication was to compare and correlate retinal microcirculation and function in patients with non-proliferative diabetic retinopathy…
Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy-ok

Early retinal neurovascular impairment in patients with diabetes without clinically detectable retinopathy

Janeiro 1, 2019
Zeng Y, Cao D, Yu H, et al. British Journal of Ophthalmology 2019;103:1747-1752.

Neurodegeneration in non‐proliferative diabetic retinopathy: new biomarkers and their relation to vasculopathy and visual function.

Dezembro 12, 2018
Nguyen A, Naso S, Mouna A, Kardon R, Kawasaki A. Acta Ophthalmologica. Vol 96. ; 2018:88-89.
Role of a Mydriasis-Free

Role of a Mydriasis-Free, Full-Field Flicker ERG Device in the Detection of Diabetic Retinopathy

Outubro 17, 2018
The purpose of this research is to determine if the RETeval system can be used for the screening of diabetic retinopathy (DR)…
diabetes-and-its-complications

A novel device for accurate and efficient testing for vision-threatening diabetic retinopathy

Abril 1, 2016
Author(s): Maa, A. Y., W. J. Feuer, C. Q. Davis, E. K. Pillow, T. D. Brown, R. M. Caywood, J…

Current and Next Generation Portable Screening Devices for Diabetic Retinopathy

Fevereiro 16, 2016
Micheletti JM, Hendrick AM, Khan FN, Ziemer DC, Pasquel FJ. Current and Next Generation Portable Screening Devices for Diabetic Retinopathy. Published online February 16, 2016.
LKC Logo

New Technologies in Diabetic Retinopathy

Janeiro 1, 2016
Author(s): Magdalena Gaca-Wysocka, Andrzej Grzybowski Publication: Ophthalmic Care for the Diabetic Patient – selected international experiences., Publisher: Foundation of Ophthalmology Development…
LKC Logo

New Handheld, Non-Mydriatic ERG Device to Screen for Diabetic Retinopathy and Other Eye Diseases

Janeiro 1, 2014
Author(s): Kim, Don B, Ross, Evelyn, Pham, Kimberly, Nguyen, Jenny, Nam, Vinna, Gunasekaran, Vidhya, Brodie, Scott E, Wu, Gloria Poster presented…
  • Produtos
    • RETeval
    • UTAS mf/PERG
    • Tiras de sensor
    • RETevet
  • Testes de Eletrofisiologia
    • Electroretinography (ERG)
    • ERG de campo completo (ffERG)
    • Padrão ERG (PERG)
    • ERG multifocal (mfERG)
    • Potencial Evocado Visual (PEV)
    • Endereço2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • Telefone+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • DISTRIBUIDORES INTERNACIONAIS
      • Distribuidores de dispositivos médicos
      • Distribuidores de dispositivos veterinários
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • Accessibility Statement
  • Terms & Conditions
  • Certifications
  • Privacy Policy
  • Careers

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity